| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UKNOWN |
| UNII: | 20TC155L9C |
Structure
| InChI Key | PANKHBYNKQNAHN-MQQNZMFNSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C20H24O4 |
| Molecular Weight | 328.41 |
| AlogP | 4.61 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 74.6 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 24.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 28000 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Intermittent Claudication | 1 | D007383 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 3918 |
| ChEMBL | CHEMBL464792 |
| DrugBank | DB05974 |
| FDA SRS | 20TC155L9C |
| KEGG | C08588 |
| SureChEMBL | SCHEMBL20977 |
| ZINC | ZINC000004097701 |
CONTENTS